Printer Friendly
The Free Library
7,774,290 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Medtronic Announces First DIAM(TM) Spinal Stabilization System Surgeries in European Post Market Study.


TOLOCHENAZ, Switzerland -- Medtronic, Inc. (NYSE NYSE

See: New York Stock Exchange
: MDT MDT
abbr.
Mountain Daylight Time


MDT (in the US and Canada) Mountain Daylight Time

MDT n abbr (US) (= mountain daylight time) →
) today announced the enrollment of the first two patients in the European post market clinical study using the DIAM[TM] Spinal Stabilization System. The first two surgeries were performed on Nov. 24 by Dr. Gianluca Maestretti of the Hypital Cantonal Fribourg, Switzerland, and Dr. Ferdinand Krappel of the Medizinisches Zentrum Kreis Aachen, Wuerselen, Germany.

These surgeries are part of a randomized ran·dom·ize  
tr.v. ran·dom·ized, ran·dom·iz·ing, ran·dom·iz·es
To make random in arrangement, especially in order to control the variables in an experiment.
, controlled clinical trial controlled clinical trial,
n a research strategy that calls for two samples: an experimental sample of patients receiving a pharmaceutical, and a second sample of control patients receiving a placebo.
 that is comparing Medtronic's DIAM Spinal Stabilization System to a standard disc herniectomy. The DIAM Spinal Stabilization System is currently affixed af·fix  
tr.v. af·fixed, af·fix·ing, af·fix·es
1. To secure to something; attach: affix a label to a package.

2.
 with a CE Mark and available for distribution in the European market, but not approved for use in the U.S. Evidence collected from this trial will be used to improve treatment decisions for better patient outcomes. Patients are being randomized into either an investigational group, consisting of a herniectomy supplemented by the DIAM Spinal Stabilization System, or a control group, consisting of patients who will undergo a standard herniectomy. Herniectomy is the standard of care for addressing leg pain caused by disc herniation herniation /her·ni·a·tion/ (her?ne-a´shun) abnormal protrusion of an organ or other body structure through a defect or natural opening in a covering, membrane, muscle, or bone. . When combined with a standard herniectomy, the DIAM Spinal Stabilization System may result in a therapy solution that provides both leg and back pain relief for the patient.

The DIAM Spinal Stabilization System implant is placed between the spinous processes (the visible ridges of the back) and is designed to act as a shock absorber shock absorber, device for reducing the effect of a sudden shock by the dissipation of the shock's energy. On an automobile, springs and shock absorbers are mounted between the wheels and the frame.  that reduces weight on the surrounding vertebrae Vertebrae
Bones in the cervical, thoracic, and lumbar regions of the body that make up the vertebral column. Vertebrae have a central foramen (hole), and their superposition makes up the vertebral canal that encloses the spinal cord.
. The core of the DIAM System is made of medical-grade silicone, while the outer mesh and tethers are made of polyester. The flexible properties of the DIAM System materials may also protect the integrity of the spinous process.

Patients will be evaluated for differences in pain relief, physical disability and quality of life as well as further progression of their disc disease. The study is assessing the short and long-term effectiveness and patient perception of benefit with the use of the DIAM Spinal Stabilization System in the treatment of complex disc disease. This is a multicentre study with 20 investigational centres within Western Europe Western Europe

The countries of western Europe, especially those that are allied with the United States and Canada in the North Atlantic Treaty Organization (established 1949 and usually known as NATO).
.

Additional information on back pain and the DIAM Spinal Stabilization System can be found at www.back.com/clinicaltrial.

About the Spinal Business at Medtronic

The Spinal business at Medtronic, based in Memphis, Tenn., is the global leader in today's spine market and is committed to advancing the treatment of spinal conditions. The Spinal business collaborates with world-renowned surgeons, researchers and innovative partners to offer state-of-the-art products and technologies for neurological, orthopedic and spinal conditions. Medtronic is committed to developing affordable, minimally invasive procedures that provide lifestyle friendly surgical therapies. More information about the company and its spinal treatments can be found at www.medtronicspinal.com and its patient-education Web sites, www.back.com, www.iscoliosis.com, www.maturespine.com and www.necksurgery.com.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended April 28, 2006. Actual results may differ materially from anticipated results.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 18, 2006
Words:531
Previous Article:Prism's Truck Blue Book Launches Truck Blue Book Online.
Next Article:North American Technology Service and Support Spending Expected to Top $1.4 Billion for 2007, According to the SSPA.
Topics:



Related Articles
Metastatic spine tumors.(Original Article)
JUST WHAT THE DOCTOR ORDERED: $1.35 BILLION SETTLEMENT.(News)
Medtronic Reports Second Quarter Revenue Growth of 15% and 23% Growth in Diluted EPS Before Special Items; After Special Items, as Reported Diluted...
Spinal hydatid disease.(Editorial)
FDA Approves Clinical Trial for Medtronic's DIAM(TM) Spinal Stabilization System.
First Patient Enrolled in Medtronic's Clinical Trial of the DIAM Spinal Stabilization System.
FDA Approves Clinical Trial For Medtronic's DIAM Spinal Stabilization System.
Medtronic Applauds Sport Study Confirmation of Positive Outcomes for Spinal Surgery Patients.(Clinical report)
Back on track: technology helps doctors turn spine surgery into outpatient procedure.(News & Analysis)
Medtronic's Cardiovascular Business Receives Product Line Leadership Award for Innovation in Cardiac Surgery.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles